MODIFICATION TO PRECINORM UNIVERSAL PLUS AND PRECIPATH UNIVERSAL PLUS CONTROL SERA

Multi-analyte Controls, All Kinds (assayed)

ROCHE DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Roche Diagnostics Corp. with the FDA for Modification To Precinorm Universal Plus And Precipath Universal Plus Control Sera.

Pre-market Notification Details

Device IDK042389
510k NumberK042389
Device Name:MODIFICATION TO PRECINORM UNIVERSAL PLUS AND PRECIPATH UNIVERSAL PLUS CONTROL SERA
ClassificationMulti-analyte Controls, All Kinds (assayed)
Applicant ROCHE DIAGNOSTICS CORP. 9115 HAGUE RD. Indianapolis,  IN  46250
ContactTheresa M Ambrose
CorrespondentTheresa M Ambrose
ROCHE DIAGNOSTICS CORP. 9115 HAGUE RD. Indianapolis,  IN  46250
Product CodeJJY  
CFR Regulation Number862.1660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-09-02
Decision Date2004-09-14
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.